ArticleKidney international2022

Acute kidney injury in patients receiving pembrolizumab combination therapy versus pembrolizumab monotherapy for advanced lung cancer.

Shruti Gupta et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.